📋 ANI PHARMACEUTICALS INC (ANIP) - Financial Results
Filing Date: 2026-05-08
Accepted: 2026-05-08 06:56:34
Event Type: Financial Results
Event Details:
ANI PHARMACEUTICALS INC (ANIP) Reports the reporting period Financial Results
ANI PHARMACEUTICALS INC (ANIP) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 93582
Net Income: 43727
EPS: 2.05
Cash and equivalents: 311176
“We delivered a strong first quarter, generating $
5 million in revenue and $
0 million in adjusted non
targeting opportunities in acute gouty arthritis, and an overall increase in activities to support the growth of our business. These increases are tempered by $9.0 million litigation settlement recognized in the GAAP figures.On a GAAP basis, the Company reported net income attributable to common shareholders of $29.5 million, or $1.28 per diluted share, for the first quarter of 2026
📋 ANI PHARMACEUTICALS INC (ANIP) - Financial Results
Filing Date: 2026-05-08
Accepted: 2026-05-08 06:56:34
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: